Pioneering the Future of Infection Diagnostics

AI-powered blood tests that predict infection before symptoms appear. Clean, tech-forward clinical setting with healthcare professionals

Presymptom Health is a medtech company developing a portfolio of patented AI-based diagnostic blood tests that are both faster and more reliable than those available today. Our mission is to transform infection management by identifying the signs of infection before they surface – helping clinicians make faster, better decisions.

Leadership Team

Nadia Whittley | CEO | Presymptom Health

Nadia Whittley

CEO

Visionary healthcare executive with deep experience in commercialising medtech and life science innovations across global markets.

Tim Davison

CTO

Specialist in diagnostic technologies, Tim leads development of Presymptom’s AI platform and supports system integration across healthcare settings.

Jacqui Stockley

Clinical Director

A senior clinician with expertise in trial management, Jacqui bridges Presymptom’s innovation with the needs of NHS patients and hospital workflows.

Scientific & Clinical Advisors

Prof Mervyn Singer

Professor of Intensive Care Medicine, UCL

Dr Paul Schmidt

Chief Investigator & ED Consultant

Devanshi Pandit

Clinical Trials Manager

Stephen Quinn

Regulatory

Board Of Directors

Dr Tito Bacarese-Hamilton

Board Chair

Nadia Whittley

Presymptom Health CEO
Board Director

Dr Mark Gostock

Board Director
Ploughshare

Sakura Holloway

Board Observer
Future Planet Capital

Hetti Barkworth-Nanton

Board Observer
Ploughshare

From the MoD and Professor Mervyn Singer stemmed a great UK success story

Presymptom Health was founded from groundbreaking research conducted by the UK’s Defence Science and Technology Laboratory (DSTL) and Professor Mervyn Singer. What started as a large-scale sepsis study led to the development of a new way to detect infection before symptoms appear.

Today, Presymptom Health is taking that technology to market through its first product, InfectiClear – a predictive diagnostic built to transform how we manage infection risk in hospitals and beyond.